PLSE
Pulse Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 0
stock price surged significantly
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About PLSE
Pulse Biosciences, Inc.
A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors
Healthcare Equipment and Supplies
05/19/2014
05/18/2016
NASDAQ Stock Exchange
75
12-31
Common stock
3957 Point Eden Way, Hayward, CA 94545
--
Pulse Biosciences, Inc., incorporated in Nevada on May 19, 2014 under the name Electroblate, Inc., is a medical device company using a new and proprietary platform technology, nano-pulsed electrical signaling, or NPES in the developmental stage of biomedical applications. Electroblate, Inc., was renamed Pulse Biosciences Corporation, effective December 8, 2015.
Company Financials
EPS
PLSE has released its 2024 Q4 earnings. EPS was reported at -0.17, versus the expected -0.24, beating expectations. The chart below visualizes how PLSE has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available